KFO309 - The clinical research unit Virus Induced Lung injury

All Publications

ATAC-seq footprinting unravels kinetics of transcription factor binding during zygotic genome activation

Bentsen M, Goymann P, Schultheis H, Klee K, Petrova A, Wiegandt R, Fust A, Preussner J, Kuenne C, Braun T, Kim J, Looso M

Nat Commun 2020 Aug 26;11(1):4267. doi: 10.1038/s41467-020-18035-1

Commercially available transfection reagents and negative control siRNA are not inert

Kleefeldt JM, Pozarska A, Nardiello C, Pfeffer T, Vadász I, Herold S, Seeger W, Morty RE

Anal Biochem 2020 Oct 1;606:113828. doi: 10.1016/j.ab.2020.113828

Acute kidney injury and urinary biomarkers in hospitalized patients with coronavirus disease-2019

Husain-Syed F, Wilhelm J, Kassoumeh S, Birk HW, Herold S, Vadász I, Walmrath HD, Kellum JA, Ronco C, Seeger W

Nephrol Dial Transplant 2020 Jul 1;35(7):1271-1274. doi: 10.1093/ndt/gfaa162

Platon: identification and characterization of bacterial plasmid contigs in short-read draft assemblies exploiting protein sequence-based replicon distribution scores

Schengers O, Barth P, Falgenhauer L, Hain T, Chakraborty T, Goesmann A

Microbial Genomics 2020 doi 10.1099/mgen.0.000398

Laboratory characteristics of patients infected with the novel SARS-CoV-2 virus

Skevaki C, Fragkou PC, Cheng C, Xie M, Renz H

J Infect 2020 doi.org/10.1016/j.jinf.2020.06.039

J Cyst Fibros 2021;20:140-148. doi.org/10.1016/j.jcf.2020.05.006

Chillappagari S, Garapati V, Mahavadi P, Naehrlich L, Schmeck BT, Schmitz ML, Guenther A


Eur Respir Rev 2020 29: 200126; DOI: 10.1183/16000617.0126-2020

Korfei M, MacKenzie B, Meiners S


Cyclophilin Inhibitors Restrict Middle East Respiratory Syndrome Coronavirus Via Interferon λ In Vitro And In Mice

Sauerhering L, Kupke A, Meier L, Dietzel E, Hoppe J, Gruber AD, Gattenloehner S, Witte B, Fink L, Hofmann N, Zimmermann T, Goesmann A, Nist A, Stiewe T, Becker S, Herold S, Peteranderl C

ERJ 2020; DOI: 10.1183/13993003.01826-2019

Using Experimental Models to Identify Pathogenic Pathways and Putative Disease Management Targets in Bronchopulmonary Dysplasia

Morty R

Neonatology doi:10.1159/000506989

Current and Future Point-of-Care Tests for Emerging and New Respiratory Viruses and Future Perspectives

Nelson P, Rath BA, Fragkou P, Antalis E, Tsiodras S, Skevaki C on behalf of the ESCMID Study Group for Respiratory Viruses (ESGREV)

Front Cell Infect Microbiol 2020 10:181

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, Talavera-López C, Maatz H, Reichart D, Sampaziotis F, Worlock KB, Yoshida M, Barnes JL & HCA Lung Biological Network

Nature Medicine 2020 26,681-687

Evidence for Overlapping and Distinct Biological Activities and Transcriptional Targets Triggered by Fibroblast Growth Factor Receptor 2b Signaling between Mid- and Early Pseudoglandular Stages of Mouse Lung Development

Jones M, Lingampally A, Wu J, Sedighi J, Ahmadvand N, Wilhelm J, Vazquez-Armendariz I, Herold S, Chen C, Zhang JS, Bellusci S, Chao CM

Cells 2020 9:1274

Failure to Down-Regulate miR-154 Expression in Early Postnatal Mouse Lung Epithelium Suppresses Alveologenesis, with Changes in Tgf-β Signaling Similar to those Induced by Exposure to Hyperoxia

Chao CM, Carraro G, Rako ZA, Kolck J, Sedighi J, Zimmermann V, Moiseenko A, Wilhelm J, Young BM, Chong L, Wu J, Contreras A, Minoo P, Barreto G, Warburton D, Bellusci S

Cells 2020 Apr 2;9(4). pii: E859. doi: 10.3390/cells9040859

Virus-Induced T Cell-Mediated Heterologous Immunity and Vaccine Development

Balz K, Trassl L, Härtel V, Nelson PP, Skevaki C

Front Immunol 11:513. doi: 10.3389/fimmu.2020.00513

Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (−) and the eIF4A-inhibitor Silvestrol

Müller C, Obermann W, Schulte FW, Lange-Grünweller K, Oesterreich L, Elgner F, Glitscher M, Hildt E, Singh K, Wendel H-G, Hartmann RK, Ziebuhr J, Grünweller A

Antiviral Res 2020 175:104706, doi.org/10.1016/j.antiviral.2020.104706